TC BioPharm (Holdings) PLC (TCBP)
1.50
+0.07
(+4.90%)
USD |
NASDAQ |
May 01, 16:00
1.50
0.00 (0.00%)
After-Hours: 19:41
TC BioPharm Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 4.601M |
Date | Value |
---|---|
June 30, 2022 | 2.627M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.627M
Minimum
Jun 2022
4.601M
Maximum
Dec 2022
3.614M
Average
3.614M
Median
Revenue (TTM) Benchmarks
Adaptimmune Therapeutics PLC | 60.28M |
Biodexa Pharmaceuticals Plc | 0.4761M |
NuCana PLC | -- |
Autolus Therapeutics PLC | -- |
Mereo BioPharma Group PLC | 10.00M |